Greenwich Wealth Management LLC

Position in ANVS — Annovis Bio, Inc.

CIK 1439805 GREENWICH, CT

Position in ANVS

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$90,024

-$14,786 QoQ

Shares Held

48,400

+3.0% QoQ

Ownership

0.114%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#18

of 61 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Greenwich Wealth Management LLC holds $13,031,117 across 5 Biotechnology names. ANVS ranks #3 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	16,094	$10,035,252
2	PRME	Prime Medicine, Inc.	768,001	$2,833,923
3	ANVS	Annovis Bio, Inc. This page	48,400	$90,024
4	AGEN	Agenus Inc	12,000	$36,720
5	INO	Inovio Pharmaceuticals, Inc.	31,999	$35,198

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$90,024	48,400	+3.0%	Shares	Sole	2026-08-12
2026-03-31	$104,810	47,000	+10.8%	Shares	Sole	2026-05-12
2025-12-31	$146,704	42,400	-10.5%	Shares	Sole	2026-02-10
2025-09-30	$98,118	47,400	+0.9%	Shares	Sole	2025-11-12
2025-06-30	$101,990	47,000	+2.0%	Shares	Sole	2025-08-13
2025-03-31	$69,150	46,100	+44.3%	Shares	Sole	2025-05-12
2024-12-31	$160,713	31,951	+93.9%	Shares	Sole	2025-02-10
2024-09-30	$132,788	16,475	+9.3%	Shares	Sole	2024-10-29
2024-06-30	$86,832	15,075	+19.9%	Shares	Sole	2024-08-09
2024-03-31	$149,642	12,575	+22.4%	Shares	Sole	2024-05-13
2023-12-31	$192,142	10,275	—	Shares	Sole	2024-02-01
No filing history on record for this holder in this stock.